The Division of Cardiology continues to grow rapidly, adding new faculty and programs, while maintaining the commitment to outstanding patient care, education and research. Innovative therapies available in the MUSC cath lab include ASD closures, left atrial appendage occlusion, renal nerve denervation, percutaneous valve repair, LDL aphoresis and alcohol septal ablation for hypertrophic cardiomyopathy. Adrian VanBakel, MD, PhD leads a comprehensive program for Congestive Heart Failure and transplantation. The Division is active in the implantation of LVADS, led by Jennifer Peura, MD; systolic heart failure, led by Michael Craig, MD and diastolic heart failure, led by Michael Zile, MD. A unique state-wide network is in place for research and clinical management of these patients.
Despite increasing competition, referrals to MUSC have increased dramatically over the past five years. Clinical services provided include general cardiology, electrophysiology, cardiac catheterization, imaging, congenital heart disease, congestive heart failure and cardiac transplant. MUSC was one of the first five centers in the world to use a 64-slice CT machine for cardiac imaging and remains a leader in this field.
Under the direction of Michael Craig, MD, our fellowship programs continue to grow. This highly competitive program receives over 400 applications annually for the six available slots. Graduates of the three-year General Cardiology Fellowship Program have a greater than 95 percent pass rate on their Cardiology Boards. Formal subspecialty training is also available in interventional cardiology and electrophysiology.
Don Menick, PhD, Professor and Director of the Gazes Cardiac Research Institute leads a flourishing basic research program. He also serves as Director of the Molecular and Cellular Biology and Pathobiology Program (MCBP), and Director of the National Institutes of Health (NIH) Summer Research Program for Minority Medical Students.
The Division also supports a successful clinical research program with 52 on-going trials in the areas of cardiac arrhythmias, congestive heart failure, coronary intervention, preventative cardiology and cardiac transplantation. Division faculty members currently serve as national or worldwide principal investigators on six multi-center clinical trials.
Dr. Christopher Nielsen leads the MUSC interventional cardiac program. He has conducted a large number of clinical trials and has introduced an impressive number of new interventional techniques to MUSC.